Patents/Inventors

Lykke Pedersen

HørsholmDK22 patents

12 Patents

US126167142026
Enhanced Oligonucleotides for Modulating FUBP1 Expression
Hoffmann-la Roche Inc.
0 cites
US125961182026
Oligonucleotides for Inducing Paternal UBE3A Expression
Hoffmann-la Roche Inc.
0 cites
US125661722026
Oligonucleotides for Inducing Paternal UBE3A Expression
Hoffmann-la Roche Inc.
0 cites
US125528622026
Oligonucleotides for Reduction of PD-L1 Expression
HOFFMANN-LA ROCHE Inc.
0 cites
US124976212025
Oligonucleotides for Modulating RTEL1 Expression
Hoffmann-la Roche Inc.
0 cites
US123035252025
Nucleic Acid Molecule for Reduction of PAPD5 and PAPD7 Mrna for Treating Hepatitis B Infection
HOFFMAN-LA ROCHE Inc.
0 cites
US122593802025
Oligonucleotides for Inducing Paternal UBE3A Expression
Hoffmann-la Roche Inc.
0 cites
US121165762024
Oligonucleotides for Modulating SCN9A Expression
Hoffmann-la Roche Inc.
0 cites
US118981452024
Enhanced Oligonucleotides for Inhibiting RTEL1 Expression
Hoffmann-la Roche Inc.
0 cites
US118526272023
Oligonucleotides for Inducing Paternal UBE3A Expression
Hoffmann-la Roche Inc.
0 cites
US117322622023
Use of FUBP1 Inhibitors for Treating Hepatitis B Virus Infection
0 cites
US115425012023
Antisense Oligonucleotides Targeting ATXN3
HOFFMANN-LA ROCHE Inc.
0 cites